Clinicians from Swedish Cancer Institute to Present Clinical Case for Elekta's VMAT Solution

Interactive workshop to take place during American Radium Society’s 91st Annual Meeting

Atlanta, GA United States — Wednesday, April 1, 2009

Vivek Mehta, MD, Director of the Center for Advanced Targeted Radiation Therapies and Daliang Cao, PhD, Medical Physicist at the Swedish Cancer Institute, Seattle, Washington, will present a workshop entitled, 4D Image Guided VMAT: A New Revolution in Human Care, Sunday, April 26, 1:00 p.m. at the Four Seasons Vancouver Hotel, Vancouver, British Columbia.

The workshop will take place during the American Radium Society’s 91st Annual Meeting, and will demonstrate how Elekta’s Volumetric Modulated Arc Therapy (VMAT) solution can improve both clinical quality and operational efficiency for radiation therapy programs.

VMAT is a clinically supported, widely accepted treatment technique for cancer care that offers patients shortened treatment times while providing more precise control of the radiation dose to maximize safety to nearby normal tissues.

For additional information and to register for the event, visit elekta.com/ars. For the latest Elekta VMAT news, visit elekta.com/elekta_vmat.

 

###

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.

Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb.

Visit Elekta - www.elekta.com

Press Releases

For further information, please contact

Stina Thorman, Vice President Corporate Communications, Elekta AB
Tel: +46 8 587 254 37
Email: stina.thorman@elekta.com
Time zone: CET: Central European

Michelle Lee, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447
Email: michelle.lee@elekta.com
Time zone: EDT: Eastern Daylight Time